Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy
about
Micronutrients in Oncological InterventionMechanisms involved in the development of chemotherapy-induced neuropathyNatural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewIdentifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics TechnologyChemotherapy-induced neuropathies-a growing problem for patients and health care providersMitotoxicity in distal symmetrical sensory peripheral neuropathiesPaclitaxel-induced increase in mitochondrial volume mediates dysregulation of intracellular Ca2+ in putative nociceptive glabrous skin neurons from the ratClinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancerA phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivorsNorth Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin OncologyTherapeutic strategies for cancer treatment related peripheral neuropathies.Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.Platinum-induced neurotoxicity and preventive strategies: past, present, and futureNeuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).The search for treatments to reduce chemotherapy-induced peripheral neuropathy.Enhancing nurse contributions to SWOG clinical trials.Appropriate use of complementary and alternative medicine approaches in gynecologic cancers.Management options for established chemotherapy-induced peripheral neuropathy.Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic strategies and directions for future research.Altered Blood Flow Response to Small Muscle Mass Exercise in Cancer Survivors Treated With Adjuvant TherapyUnmonitored use of herbal medicine by patients with breast cancer: reframing expectations.BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture.Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis.Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
P2860
Q26764839-2268FF13-A633-4B59-B189-9E980476350BQ26824380-74393A61-E9AD-46C7-8B00-6D1A4FB60C99Q28270819-10686021-28D8-44C9-A34F-C77B53996E17Q28551798-AB2F10CA-FDC1-4787-B0E4-405AEB650537Q28818565-B7FD1969-C88C-4B68-A2DD-36E315E0026BQ28834071-9A10161B-CF0F-44CD-9FA2-AD7BE5A28B2BQ29248252-D7EC7359-F675-4D39-A089-9077AEC1B1F3Q30234688-26EF9E0F-6207-4ABB-93FF-E99CDEACE570Q30372504-D18D0847-B614-44DD-B012-4F6ADDEFCD42Q33693343-B7BBB942-0A21-400A-9A1F-94C686C68BC6Q33717608-55A20CC2-E48D-4CA6-AF24-935980BFDE7DQ33744706-EC08229F-CAE6-422C-96F2-1BE6A6A5FBD2Q33824948-00E99A29-8233-4337-B1D1-810A7567621FQ34245549-B1A17ADB-0BC2-4DCE-8660-2C807CD0F36EQ34433406-07FBDF83-006B-47B5-9BED-F2861F4B6E3DQ34458581-A9A3F1D2-25AC-43D8-8FE0-85C2268F5774Q34685307-DB5C2695-9D77-4C34-804C-4017C02E0F7BQ35121171-C25C4B64-10E4-4E3F-9891-21460CF5080BQ35345734-D1AEFC9D-63B8-4122-83AA-67071D1E6550Q35778696-D9929EB4-DE72-433F-AC9F-F12FD96C23B5Q36226275-6CAB5B9B-BBF1-4B13-B6C2-EF242C1093F9Q37227426-CA6F8304-B06F-487C-AE2D-36EF9AD56DEAQ37301431-9DA232BD-3DFD-4F64-A973-28653450AE30Q37364316-49C347D3-B90B-40C7-B7AA-EBEFA85D9720Q37399781-406F8AB5-1656-42D5-9EE2-FA9F2381D319Q37410650-3DABB81C-B5E5-4BD1-A059-9A7D45DE8281Q37651986-639F8D5B-000F-4BC8-AD6D-5CD9CE2FA0D8Q38176506-1CDA6588-A924-4407-B170-0B5A84B0385FQ38216217-ECB98032-41BA-406F-99A6-29B4D4CD3E20Q38264622-E259AD70-53F1-4BA4-A3CA-96F536E84656Q38426849-08513462-AE77-48C1-B739-B9A6F16308BCQ38716340-EFE916DD-A7EE-4825-BF6B-C67CCBC48587Q38769139-B4631EB8-8319-4C1E-84E6-0FBD875E7AC0Q38973438-385E066E-2163-40B9-A6F4-227C5C349B40Q39153420-0EFAA882-9619-4553-A8B6-889D34FA1924Q39236303-C25EC455-451A-4046-86CC-52017A659D42Q39283600-FFE99132-1AB2-4CF8-8849-87E1C928A684Q41346602-C6633EC8-0DFA-445A-ADE9-AECFF3C2BB60Q47103663-E17BBF9F-A3CB-41C7-B246-62B21FABD6C9Q47552411-9057ACA3-A5BA-41C9-9FEE-03DE59E0D778
P2860
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Randomized double-blind placeb ...... adjuvant breast cancer therapy
@en
type
label
Randomized double-blind placeb ...... adjuvant breast cancer therapy
@en
prefLabel
Randomized double-blind placeb ...... adjuvant breast cancer therapy
@en
P2093
P2860
P356
P1476
Randomized double-blind placeb ...... adjuvant breast cancer therapy
@en
P2093
Carol M Moinpour
Danielle Awad
Danika L Lew
Frank L Meyskens
Gabriel N Hortobagyi
Heather Greenlee
James L Wade
Joseph M Unger
Katherine D Crew
Kathy S Albain
P2860
P304
P356
10.1200/JCO.2012.44.8738
P407
P577
2013-06-03T00:00:00Z